In the multivariable base model of analysis (B1.a), SSRI and liver disease remained associated with a higher chance of exhibiting a GI bleeding, while for the outcome drug-related hypoglycaemia, any insulin, heart failure and all types of DM remained associated with this outcome in the analysis (H1.a). This evidence concerns the gene INS and diabetes mellitus.